Review: taking Vicodin and Vimovo together


Summary

Drug interactions are reported among people who take Vicodin and Vimovo together. This review analyzes the effectiveness and drug interactions between Vicodin and Vimovo. It is created by eHealthMe based on reports of 39 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Vicodin

Vicodin has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. (latest outcomes from Vicodin 45,484 users)

Vimovo

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. (latest outcomes from Vimovo 1,575 users)

On Sep, 17, 2016

39 people who take Vicodin, Vimovo are studied.


Number of reports submitted per year:

Vicodin and Vimovo drug interactions.

Drug effectiveness over time:

Vicodin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Vimovo:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Vicodin:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)
Vimovo:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Vicodin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Vimovo:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • musculoskeletal pain
  • adverse event
  • intervertebral disc degeneration
  • pulmonary function test decreased
  • abdominal discomfort
  • diarrhoea
  • hypertension
  • perirectal abscess
1 - 6 months:
  • fatigue
  • gastrooesophageal reflux disease
  • headache
  • gastrointestinal ulcer
  • arrhythmia
  • carotid artery stenosis
  • cerebrovascular accident
  • cough
  • drug hypersensitivity
  • dyspepsia
2 - 5 years:
  • joint pain
  • muscle weakness
  • shaking palsy
not specified:
  • fatigue
  • headache
  • depression
  • fall
  • gastritis
  • dyspepsia
  • compression fracture
  • constipation
  • death
  • dizziness

Most common drug interactions by gender *:

female:
  • fatigue
  • headache
  • depression
  • dyspepsia
  • fall
  • gastritis
  • compression fracture
  • constipation
  • death
  • malnutrition
male:
  • haematochezia
  • abdominal discomfort
  • adverse event
  • anaemia postoperative
  • blood pressure decreased
  • blood pressure increased
  • blood urine present
  • cardiac failure congestive
  • chest discomfort
  • diarrhoea

Most common drug interactions by age *:

30-39:
  • gastrointestinal ulcer
  • abdominal discomfort
  • arthritis
  • behcet's syndrome
  • fibromyalgia
  • nausea
  • rheumatoid arthritis
  • total lung capacity decreased
  • visual field defect
40-49:
  • joint pain
  • muscle weakness
  • shaking palsy
  • abdominal discomfort
  • diarrhoea
50-59:
  • headache
  • dyspepsia
  • depression
  • fatigue
  • weight increased
  • arthralgia
  • asthenia
  • dizziness
  • dry eye
  • dry mouth
60+:
  • fatigue
  • compression fracture
  • constipation
  • death
  • fall
  • gastritis
  • malnutrition
  • adverse event
  • blood urine present
  • chest discomfort

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Vicodin and Vimovo?

Can you answer these questions?

More questions for: Vicodin, Vimovo

You may be interested in these reviews

More reviews for: Vicodin, Vimovo

On eHealthMe, Vicodin (acetaminophen; hydrocodone bitartrate) is often used to treat pain. Vimovo (esomeprazole magnesium; naproxen) is often used to treat osteoarthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.